Most recently, it has been identified that conolidine and the above derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in very similar areas as classical opioid receptors, it binds to a wide array of endogenous opioids. Not like most opioid receptors, this receptor acts for a scavenger https://stephend420bde1.wikijm.com/user